Are you Dr. Francis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3375 SW Terwilliger Blvd
Portland, OR 97239Phone+1 503-494-7891Fax+1 503-494-7233
Summary
- Dr. Peter Francis, MD is an ophthalmologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Michigan, and Washington. He is affiliated with OHSU Hospital and St. Charles Prineville.
Education & Training
- University of Southampton Faculty of MedicineClass of 1992
Certifications & Licensure
- WA State Medical License Current
- OR State Medical License 2009 - 2025
- MI State Medical License 1990 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD Start of enrollment: 2007 May 01
- Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 3 citationsViral Vector Technologies and Strategies: Improving on Nature.Roxanne H. Croze, Melissa A. Kotterman, Christian H. Burns, Chris E. Schmitt, Melissa Quezada
International Ophthalmology Clinics. 2021-07-01 - 3 citationsQuantification of RPE Changes in Choroideremia Using a Photoshop-Based Method.Yi Zhai, Manlong Xu, Ioannis S. Dimopoulos, David G. Birch, Paul S. Bernstein
Translational Vision Science & Technology. 2020-06-03 - Errors in Potential Conflicts of Interest Disclosures, Author Affiliation, and Role of Funder.Stephen Rose, Patricia Zilliox, Peter J. Francis
JAMA Ophthalmology. 2018-12-01
Press Mentions
- 4D Molecular Therapeutics Expands Leadership Team with Appointments and Promotions of Key ExecutivesFebruary 19th, 2019
- Correction of Potential Conflicts of Interest Disclosures, Author Affiliation, and Role of FunderSeptember 13th, 2018
- New Trial Hopes to Restore Sight of Severe-Stage Retinitis Pigmentosa PatientsFebruary 24th, 2016